These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24751753)

  • 41. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis.
    Jones RB
    Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J; Radhakrishnan J
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Membranoproliferative glomerulonephritis with IgA deposits in patients with alcoholic cirrhosis.
    Ferrario G; Palazzi P; Torri Tarelli L; Volpi A; Meroni M; Giordano F; Sessa A
    Pathologica; 1986; 78(1056):469-78. PubMed ID: 3615024
    [No Abstract]   [Full Text] [Related]  

  • 44. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
    Miyabe Y; Takei T; Iwabuchi Y; Moriyama T; Nitta K
    Clin Exp Nephrol; 2016 Feb; 20(1):103-10. PubMed ID: 26138356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome.
    Fenoglio R; Sciascia S; Beltrame G; Mesiano P; Ferro M; Quattrocchio G; Menegatti E; Roccatello D
    Oncotarget; 2018 Jun; 9(48):28799-28804. PubMed ID: 29989000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.
    Alasfar S; Matar D; Montgomery RA; Desai N; Lonze B; Vujjini V; Estrella MM; Manllo Dieck J; Khneizer G; Sever S; Reiser J; Alachkar N
    Transplantation; 2018 Mar; 102(3):e115-e120. PubMed ID: 29189487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.
    Niu XL; Hao S; Wang P; Zhang W; Guo GM; Wu Y; Kuang XY; Zhu GH; Huang WY
    Biomed Rep; 2016 Aug; 5(2):237-242. PubMed ID: 27446549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephrotic syndrome: Efficacy of rituximab in challenging nephrotic syndrome.
    Lemley KV; Mak RH
    Nat Rev Nephrol; 2015 May; 11(5):257-8. PubMed ID: 25752834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies for renal diseases: current concepts and ongoing treatments.
    Santoro D; Pellicanò V; Visconti L; Trifirò G; Cernaro V; Buemi M
    Expert Opin Biol Ther; 2015; 15(8):1119-43. PubMed ID: 26087994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ret is critical for podocyte survival following glomerular injury in vivo.
    Hou G; Wu V; Singh G; Holzman LB; Tsui CC
    Am J Physiol Renal Physiol; 2015 Apr; 308(7):F774-83. PubMed ID: 25587123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between autoantibodies and peripheral neuropathy in lupus nephritis.
    Su YJ; Huang CR; Chang WN; Tsai NW; Kung CT; Lin WC; Huang CC; Su CM; Cheng BC; Chang YT; Lu CH
    Biomed Res Int; 2014; 2014():524940. PubMed ID: 24864250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alemtuzumab plus cyclosporine treatment of the autoimmune hemolytic anemia in an adult bowel transplant.
    Lauro A; Stanzani M; Finelli C; Zanfi C; Morelli MC; Pasqualini E; Dazzi A; Ravaioli M; Di Simone M; Giudice V; Pironi L; Pinna AD
    Case Rep Transplant; 2014; 2014():262953. PubMed ID: 25177510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.
    Tzachanis D; Hamdan A; Uhlmann EJ; Joyce RM
    Acta Haematol; 2014; 132(2):240-3. PubMed ID: 24853856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report.
    Madan A
    Int J Gen Med; 2015; 8():119-24. PubMed ID: 25848316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in the understanding of immune-mediated nephrotic syndrome: diagnostic and prognostic implications.
    Timmermans SA; van Paassen P; Cohen Tervaert JW
    Expert Rev Clin Immunol; 2015 Apr; 11(4):489-500. PubMed ID: 25754988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of glomerular C4d deposition with various demographic data in IgA nephropathy patients; a preliminary study.
    Nasri H; Ahmadi A; Rafieian-Kopaei M; Bashardoust B; Nasri P; Mubarak M
    J Nephropathol; 2015 Jan; 4(1):19-23. PubMed ID: 25657981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One hundred ways to kill a podocyte.
    Saleem MA
    Nephrol Dial Transplant; 2015 Aug; 30(8):1266-71. PubMed ID: 25637640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 10-year follow-up of idiopathic membranous nephropathy patients on steroids and cyclophosphamide: a case series.
    Ram R; Guditi S; Kaligotla Venkata D
    Ren Fail; 2015 Apr; 37(3):452-5. PubMed ID: 25594615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.